Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for the use of the Renuvion APR Handpiece "for coagulation of subcutaneous soft tissues following liposuction for aesthetic body contouring."
https://finance.yahoo.com/news/apyx-medical-corporation-receives-fda-113000142.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.